AFN-0328

N/A

Report date: 2026/05/12 15:11:59

Base Information

Drug NameAFN-0328
Drug Alias NameAFN0328AFN-0328
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccineCell and gene therapy > Gene therapy > mRNA
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSquamous Intraepithelial Lesions of the CervixPapillomavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesHefei Afana Biotechnology Co LtdAnhui Anke Biotechnology (Group) Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesHefei Afana Anke Biotechnology Co LtdHefei Afana Biotechnology Co LtdAnhui Anke Biotechnology (Group) Co Ltd
Inactive CompaniesN/A
Active IndicationsSquamous Intraepithelial Lesions of the CervixPapillomavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A